Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands

Details for Australian Patent Application No. 2009354790 (hide)

Owner Bristol-Myers Squibb Company

Inventors Cook II, James H.; McDonald, Ivar M.; King, Dalton; Olson, Richard E.; Wang, Nenghui; Iwuagwu, Christiana I.; Zusi, F. Christopher; Macor, John E.

Agent A J Park

Pub. Number AU-A-2009354790

PCT Pub. Number WO2011/053292

Filing date 29 October 2009

Wipo publication date 5 May 2011

International Classifications

C07D 498/20 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

14 June 2012 PCT application entered the National Phase

  PCT publication WO2011/053292 Priority application(s): WO2011/053292

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009354806-Twist beam suspension with Y-beam control arm

2009354789-Dentifrice comprising stannous fluoride plus zinc citrate and low levels of water